Efficacy and safety of propofol with or without esketamine for outpatient sedation of children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100048536

Enrollment

Unknown

Registered

2021-07-10

Start date

2021-07-01

Completion date

Unknown

Last updated

2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

none

Interventions

Control group:Intravenous injection of propofol

Experimental group:Ketamine was injected intravenously first, followed by propofol

Eligibility

Sex/Gender

Male

Age

No minimum to 10 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1 month to 10 years; 2. ASA classification I-II grades.

Exclusion criteria

Exclusion criteria: 1. Severe heart and lung disease; 2. Upper respiratory tract infection; 3. Increased intracranial pressure; 4. Epilepsy; 5. Obesity; 6. Those with difficult airway.

Design outcomes

Primary

Measure	Time frame
Sedation success rate;Incidence of adverse reactions;	—

Countries

China

Contacts

Public ContactXing Na

The First Affiliated Hospital of Zhengzhou University

16427485@qq.com+86 13949095172

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026